Molecular Cytogenetics Market is expected to rise at a CAGR of 11% By 2022
Molecular Cytogenetics Market is expected to reach USD 2,266.4 million by 2022, at a
CAGR of 11% during the forecast period of 2017 to 2022.
Molecular cytogenetics plays an important role in diagnosis
of various diseases. Based on the type of diseases, the diagnosis can be
possible using various cytogenetic techniques such as Fluroscence In Situ
Hybridization (FISH), In Situ Hybridization, Karyotyping, Banding Techniques, and
others. The banding techniques have been used since past decades because of
their easy accessibility and availability. However, due to its drawbacks in
identifying genetic diseases at submicroscopic level, it is further modified
into in situ hybridization. Currently, the FISH plays a major role in diagnosis
of various diseases at genetic level using advanced molecular cytogenetic
products. FISH is mainly used to detect the chromosomal aberrations such as
deletion, duplication, insertion, and gene expression. It can be applicable to
any specimen. Also, it is suitable for heterogeneous breakpoints or multiple
translocation patterns. However, it has less sensitivity for detecting the
genetic abnormality and requires expertise to interpret the results as there is
a risk of getting false positive results. However, with the growing need to
diagnose diseases at molecular level, array based technologies have emerged and
preferred over FISH technique.
The global molecular cytogenetics market is mainly segmented
by technique (fluorescence in situ hybridization, comparative genomic
hybridization, in situ hybridization, karyotyping, and banding techniques), by
product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders,
personalized medicines, and other), and by end user (pharmaceuticals and
biotechnological companies, clinical and diagnostic laboratories, and academic
institutes). The comparative genome hybridization is further classified into an
array based CGH and matrix based CGH, whereas, the karyotyping market is
further segmented into Spectral Karyotyping and virtual karyotyping. Banding
techniques are further classified into G banding, R banding, C banding, Q
banding, and T banding.
The comparative genomic hybridization technology segment
commanded the largest share of the global molecular cytogenetics market and is
expected to grow at the fastest CAGR in the next five years mainly due to the
growing adoption of array CGH for various applications.
The key players in the global molecular cytogenetics market
are Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies,
PerkinElmer, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics,
Roche Diagnostics, Danaher Corporation, Illumina, and Oxford Gene Technology.
About Meticulous Research®
Meticulous Research® is founded in 2010 and
incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in North
America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Contact Us:
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004
Email: viren@meticulousresearch.com
Comments
Post a Comment